Latest Breaking News On - அரச மார்ஸ்டன் - Page 13 : comparemela.com

New drug combination attacks prostate cancer on two fronts – study (David Davies/PA) Men with particularly aggressive prostate cancers can be treated more effectively by combining an existing targeted medicine with an experimental drug, new research suggests. Using both medications extended the time before prostate cancers progressed and spread further in men whose tumours lacked a gene known as PTEN. This is one of the most commonly deleted tumour suppressor genes – which often function to restrain inappropriate cell growth and division – in cancer. Researchers assessed the efficacy of the targeted hormone drug abiraterone – standard medicine for many men with advanced prostate cancer – together with a new drug called ipatasertib in men with advanced prostate cancer who had received no prior treatment.

United kingdomCity ofInstitute of cancer researchCancer researchRoyal marsdenJohann de bonoஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சிபுற்றுநோய் ஆராய்ச்சிஅரச மார்ஸ்டன்ஜோஹான் டி போனோ